Where Should I Actually Get My Peptides?
Quick Answer
Once you've decided peptide therapy is worth exploring, you're really choosing between three different models, not just three different prices. Unregulated peptides from a gym contact or an internet research-chemical site carry real, documented contamination and mislabeling risk, with no one evaluating whether the peptide is even right for you. Internet telemedicine subscriptions solve that legitimacy problem, but they typically replace it with two others: you're choosing from a predetermined menu with no ability to go off-menu, and the visit is usually structured to sell you a specific peptide first rather than to diagnose what's actually dysfunctional and let that diagnosis determine the treatment.
A prescription plan through a full-service clinic is built to avoid all three problems at once: a tested, pharmacy-sourced product, a provider who actually knows you, and a workup that starts with your labs and history rather than a preset offering.
It is worth knowing how the real split looks. A 2026 study that used a large language model to read de-identified clinical notes from a United States network identified 1,039 patients documented as using BPC-157, and among the 205 where a source was recorded, 36 percent obtained it from a compounding pharmacy and 35 percent from gray-market peptide vendors. So the two paths below are close to evenly travelled in practice, which is the reason this question is worth thinking through rather than defaulting to whatever is easiest to order. That study also found something more practical: among patients where the timing could be established, use preceded the first mention of it in any clinical note by an average of 60 days. Most people are two months into a peptide before anyone responsible for their care knows about it.
Option One: Gym-Sourced or Internet "Research" Peptides
These are sold under research-use-only labeling specifically so the seller avoids FDA drug regulation, which also means there's no prescription, no physician oversight, and no mandatory testing standing behind what's actually in the vial. Some vendors publish honest third-party testing. Others don't, and from the outside there's no reliable way to tell which is which. A 2018 analytical chemistry study of falsified peptide products circulating on the Belgian black market found purity as low as 5% of the labeled active ingredient, with detectable arsenic and lead contamination in multiple samples (Janvier et al., 2018). That's not a worst-case outlier; it's what an unregulated, unaccountable supply chain produces routinely. Beyond the product itself, there's no one reviewing your labs or your medical history before you inject something, which means the first person evaluating whether it's appropriate for you is you.
Option Two: Internet Telemedicine Subscriptions
This model solves the sourcing problem. You get a real prescription and a pharmacy-tested product. What it typically doesn't solve is the relationship problem, and it introduces a structural one of its own. A growing number of these companies are built around recruiting people in the community, sometimes patients themselves, as referral sellers who earn a commission for bringing in new sign-ups, which is a sales structure, not a clinical one. The visit itself is usually a short video call with a provider you'll likely never speak with again, and the menu, even when it lists a reasonable number of peptides, is fixed and predetermined. There's no going off-menu for something built specifically around your labs and history.
The deeper issue is the order of operations. A model built to move volume through short visits tends to lead with the peptide: you show up already interested in a specific product, and the visit exists mainly to get you a prescription for it. Figuring out why you're actually feeling the way you're feeling, what pathway is underperforming and why, takes real time and a real relationship, and that step gets skipped or compressed when the visit is structured to sell a peptide rather than to diagnose first. The specific peptide should be the last decision in the process, made once the underlying dysfunction is understood, not the first one a patient walks in already committed to.
Option Three: A Prescription Plan Through a Full-Service Clinic
This is the model I built my practice around, and it's the reason I think it's worth the extra step compared to the other two. You sit across from a physician or nurse practitioner in person, someone who examines you and reviews your labs in the context of your actual history, and the visit starts with figuring out what's actually dysfunctional, which hormone or metabolic pathway isn't doing what it should, rather than starting with a product you've already decided you want. That process takes more time, which is exactly why it doesn't fit into a ten-minute video call built around a fixed catalog. The specific peptide, if one is even indicated, comes at the end of that workup, not the beginning, and the plan can be built entirely around you rather than pulled from a predetermined list.
The peptide itself comes from a licensed compounding pharmacy: sourced, tested, and dispensed under a real prescription, the same standard covered on the What Are Peptides page. And because it's an ongoing relationship rather than a one-time transaction, your plan gets adjusted based on how you're actually responding, not renewed automatically on a subscription schedule.
There are really three separate questions here: is the product itself legitimate, is someone building a relationship with you, and is the treatment plan built forward from your actual physiology or backward from a product they'd like to sell you. An unregulated vendor fails the first question. A telemedicine-affiliate model can pass the first and still fail the second and third. A full-service clinic is the only model of the three built to answer all three, which is the real reason it takes more time and costs more than either alternative.
If you'd like to sit down with a provider who can build a plan around your actual labs and goals rather than a fixed menu, here are all of the practices I see patients in.
View My Clinic LocationsOr email drwilcox@precisionhormoneconsulting.com · DM @wellnessdoc_4everyoung on Instagram
— Dr. Darrell Wilcox · @wellnessdoc_4everyoung on Instagram
References
- Janvier S, Cheyns K, Canfyn M, Goscinny S, De Spiegeleer B, Vanhee C, Deconinck E. Impurity profiling of the most frequently encountered falsified polypeptide drugs on the Belgian market. Talanta. 2018;188:795-807. doi:10.1016/j.talanta.2018.06.023. PMID: 30029448. (Analytical chemistry study of falsified peptide products from three suspected illegal internet pharmacies; one market, one time point, not a clinical outcomes study.)
- Venkatakrishnan A, Marwaha A, Gregg CJ, et al. Rising use of unapproved BPC-157 (“Wolverine Peptide”) and associated patient-reported outcomes curated from clinical notes. Preprint, posted 7 September 2026. doi:10.20944/preprints202609.0501.v1. (Preprint, not peer reviewed. Retrospective curation of clinical notes by large language model with physician adjudication; describes documented use patterns, not treatment outcomes, and has no control group.)
This content is for educational purposes only and does not constitute medical advice. Peptide therapies discussed here vary in FDA approval status and evidence quality, and regulatory status for compounded peptides is subject to change. Individual clinical decisions require physician evaluation and are made on a case-by-case basis. Dr. Wilcox is licensed to practice in multiple states. See About for current licensure.